Dissociation of parathyroid hormone bioactivity and immunoreactivity in pseudohypoparathyroidism type I.
Circulating levels of parathyroid hormone (PTH) in six patients with pseudohypoparathyroidism type I (PSPI) have been measured by two immunoassays and by cytochemical bioassay and compared with measurements in normal subjects and patients with clinically defined hyper- and hypoparathyroidism. In all PSPI patients, the levels of immunoreactive PTH were in the hyperparathyroid range, whereas the bioactive levels were either in the normal or close to the normal range. In one patient from whom the dihydrotachysterol therapy was withdrawn, both immunoreactive and bioactive PTH concentrations increased. The finding that the PTH measured by RIA in these PSPI patients may have reduced biological activity may explain some of the clinical findings of hypoparathyroidism in this syndrome.
D000328:Adult; D000368:Aged; D001681:Biological Assay; D002118:Calcium / Q000097:blood; D002648:Child; D005260:Female; D006651:Histocytochemistry; D006801:Humans; D006961:Hyperparathyroidism / Q000097:blood / Q000209:etiology; D008286:Malabsorption Syndromes / Q000150:complications; D008297:Male; D008875:Middle Aged; D010281:Parathyroid Hormone / Q000097:blood*; D011547:Pseudohypoparathyroidism / Q000097:blood*; D011863:Radioimmunoassay; D014808:Vitamin D Deficiency / Q000150:complications
D010281:Parathyroid Hormone; D002118:Calcium